Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
NCT Number: NCT03837847
The researchers are trying to explore the benefit of Health Coaching on patients with severe symptoms of COPD.
Looking for future studies?
Notify Me40 year and older
All sexes
Interventional
Not applicable
Rochester, Minnesota, 55905, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Men and women 40 years or older with a clinical diagnosis of COPD with shortness of breath.
Exclusion: terminal illness, inability to communicate by phone
Participants in this group will receive 12 weekly health coaching calls
Participants in this group will receive 6 educational guides
Time frame: Baseline, 3 months
The CRQ-Dyspnea is a 5-item questionnaire that assesses dyspnea on a Likert scale from 1 - 7. Higher scores indicate less severity of dyspnea.
Time frame: Baseline, 3 months
The CRQ-Fatigue is a 4-item questionnaire that assesses fatigue on a Likert scale from 1 - 7. Higher scores indicate less severity of fatigue.
Time frame: Baseline, 3 months
The CRQ-Mastery is a 4-item questionnaire that assesses mastery on a Likert scale from 1 - 7. Higher scores indicate a higher level of mastering the ability to deal with the symptoms of the disease.
Time frame: Baseline, 3 months
The CRQ-Emotions is a 7-item questionnaire that assesses emotions on a Likert scale from 1 - 7. Higher scores indicate less severity of emotions.
Time frame: Baseline,3 months
Mean change in the number of steps per day
Time frame: Baseline, 3 months
Self-Management Ability Scale-30 item questionnaire measuring ability and function. Total score range is 0-100, higher score indicated better ability and function.
Time frame: Baseline, 3 months
The MLQ is a 10-item questionnaire that assesses quality of life rated on a seven-point scale from 1 = Absolutely Untrue to 7 =Absolutely True. The Presence of Meaning subscale score = subtract the rating for item #9 from 8, then add to the ratings for items 1, 4, 5, and 6. Total Presence of Meaning Scores range between 5 and 35. Higher scores indicate more fullness of meaning a person feels in their life.
Time frame: Baseline, 3 months
The MLQ is a 10-item questionnaire that assesses quality of life rated on a seven-point scale from 1 = Absolutely Untrue to 7 =Absolutely True. The Search for Meaning subscale score = add together the ratings for items 2, 3, 7, 8, and 10. Total Search for Meaning scores range between 5 and 35. Higher scores indicate more engaged and motivated a person feels to understand and find meaning in their life
Time frame: Baseline, 3 months
The Patient Health Questionnaire 9-item (PHQ-9) scale used to assess severity of depression. Scoring is calculated by assigning scores of 0, 1, 2, and 3 to the response categories, respectively, of "not at all," "several days," "more than half the days," and "nearly every day." Total score ranges from 0 to 27 where 0 is no depression, 1-4 is minimal depression, 5-9 is mild depression, 10-14 is moderate depression, and 15-19 is moderately severe depression and 20-27 severe depression.
Time frame: Baseline,3 months
The General Anxiety Disorder 2-item (GAD 2) scale assess severity of generalized anxiety disorder. Total scores range from 0-6, a higher score indicates greater anxiety.
Mayo Clinic
Other
Mechanistic Effects of Health Coaching to Reduce COPD Hospitalizations
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05567562
COPD, Chronic Disease
Boston, Massachusetts, United States
View Trial DetailsNCT06826560
Behavior, Bronchial Diseases
Warsaw, Poland
View Trial DetailsNCT04559464
COPD, Chronic Disease
Brisbane, Australia
View Trial DetailsNCT04256408
COPD, Chronic Disease
Groningen, Netherlands
View Trial Details